Sam Ropp - Dec 15, 2023 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Commercial Officer
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Dec 15, 2023
Transactions value $
$0
Form type
4
Date filed
12/18/2023, 05:44 PM
Previous filing
Sep 15, 2023
Next filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +4.19K +50.01% 12.6K Dec 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -4.19K -7.14% 54.4K Dec 15, 2023 Common Stock 4.19K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.